E2 ModeratePreliminaryPEM not requiredCross-SectionalPeer-reviewedReviewed
Standard · 3 min
[FREQUENCY OF IMMUNOGLOBULIN E DEFICIENCY AMONG PATIENTS WITH IMMUNODEPENDENT DISORDERS].
Kazmirchuk, V Ie, Tsaryk, V V, Sydorenko, O I et al. · Likars'ka sprava · 2014
Quick Summary
This study examined nearly 5,300 patients with suspected immune problems and found that 7% had abnormally low levels of IgE, an antibody that normally helps fight infections. Among patients with this IgE deficiency, the most common symptoms were recurrent respiratory infections (63%), followed by digestive problems (13%), autoimmune conditions (10%), allergies (7%), and chronic fatigue (7%). The researchers concluded that IgE deficiency is more common than previously recognized and may contribute to various health problems.
Why It Matters
Chronic fatigue syndrome appeared in 7% of IgE-deficient patients in this study, suggesting a potential immune dysregulation mechanism relevant to ME/CFS pathophysiology. Understanding the role of IgE in immune regulation and its association with unexplained fatigue may help researchers identify immune subgroups within the ME/CFS population. This work supports investigation of selective immunoglobulin deficiencies as contributors to post-infectious fatigue syndromes.
Observed Findings
7% of 4,476 screened patients had IgE deficiency (<10 kIU/l); mean serum IgE in deficient group was 5.30 ± 1.31 IU/ml
63% of IgE-deficient patients presented with sinopulmonary syndrome; infections predominantly caused by encapsulated bacteria
7% of IgE-deficient patients presented with chronic fatigue syndrome as a clinical syndrome
Most IgE-deficient patients maintained normal levels of IgG, IgA, IgM, and lymphocyte subpopulations
Partial IgE deficiency (5–10 kIU/l) was more common than complete deficiency, occurring in 4% vs 3% of screened population
Inferred Conclusions
Isolated IgE deficiency is an underestimated primary immunodeficiency affecting approximately 7% of patients with suspected immune disorders
IgE plays a protective role in mucosal immunity against encapsulated bacteria in the respiratory tract
IgE deficiency occurs in patients with otherwise normal immune status (normal other immunoglobulin classes and cellular immunity)
Clinical surveillance and dispensary follow-up are warranted for patients with confirmed IgE deficiency
Remaining Questions
What is the prevalence of IgE deficiency in unselected populations or healthy controls versus symptomatic populations?
What This Study Does Not Prove
This study does not prove that IgE deficiency causes ME/CFS—the chronic fatigue cases described may represent coincidental overlap rather than causal relationship. The cross-sectional design cannot establish temporal relationships or rule out reverse causation. The study also does not demonstrate that IgE replacement therapy would improve outcomes in any patient group, including those with fatigue.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.
What is the mechanistic link between IgE deficiency and chronic fatigue? Is fatigue secondary to recurrent infections or a direct consequence of immune dysregulation?
Does AICDA gene polymorphism severity correlate with degree of IgE deficiency or clinical symptom burden?
Are there effective preventive or therapeutic interventions for complications of IgE deficiency, and do they improve outcomes in fatigued patients?